tiprankstipranks
iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market

iTeos Therapeutics (ITOS) Technical Analysis

Compare
182 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
iTeos Therapeutics’s (ITOS) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting iTeos Therapeutics is a Sell.
iTeos Therapeutics’s (ITOS) 20-Day exponential moving average is 7.49, while iTeos Therapeutics’s (ITOS) share price is $7.41, making it a Sell.
iTeos Therapeutics’s (ITOS) 50-Day exponential moving average is 7.82, while iTeos Therapeutics’s (ITOS) share price is $7.41, making it a Sell.

iTeos Therapeutics (ITOS) Pivot Points

Feb 23, 2025, 07:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.29
7.35
7.41
7.47
7.53
7.59
7.65
Fibonacci
7.35
7.39
7.42
7.47
7.51
7.54
7.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

iTeos Therapeutics (ITOS) Moving Averages

Feb 23, 2025, 07:26 PM
Period
Simple
Exponential
MA5
7.45Sell
7.43Sell
MA10
7.37Buy
7.44Sell
MA20
7.48Sell
7.49Sell
MA50
7.64Sell
7.82Sell
MA100
8.30Sell
8.82Sell
MA200
11.99Sell
10.88Sell
iTeos Therapeutics’s (ITOS) 10-Day exponential moving average is 7.44, while iTeos Therapeutics’s (ITOS) share price is $7.41, making it a Sell.
iTeos Therapeutics’s (ITOS) 100-Day exponential moving average is 8.82, while iTeos Therapeutics’s (ITOS) share price is $7.41, making it a Sell.
iTeos Therapeutics’s (ITOS) stock price is $7.41 and iTeos Therapeutics’s (ITOS) 50-day simple moving average is 7.64, creating a Sell signal.
iTeos Therapeutics’s (ITOS) stock price is $7.41 and iTeos Therapeutics’s (ITOS) 100-day simple moving average is 8.30, creating a Sell signal.
iTeos Therapeutics’s (ITOS) stock price is $7.41 and iTeos Therapeutics’s (ITOS) 200-day simple moving average is 11.99, creating a Sell signal.

iTeos Therapeutics (ITOS) Technical Indicators

Feb 23, 2025, 07:26 PM
Name
Value
Implied Action
RSI (14)
45.46
Neutral
STOCH (9,6)
55.97
Neutral
STOCHRSI (14)
46.36
Neutral
MACD (12,26)
-0.09
Sell
ADX (14)
11.83
Buy
Williams %R
-59.77
Buy
CCI (14)
-8.68
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
44.75
Neutral
ROC
-1.72
Sell
iTeos Therapeutics’s (ITOS) Relative Strength Index (RSI) is 45.46, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Trend Strength Indicator (ADX) is 11.83, creating a Buy signal.
iTeos Therapeutics’s (ITOS) Commodity Channel Index (CCI) is -8.68, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Price Rate of Change (ROC) is -1.72, creating a Sell signal.

FAQ

Is ITOS a Buy, Hold, or Sell?
Based on ITOS’s technical indicators, ITOS is a Sell.
    What is ITOS’s RSI (14)?
    ITOS’s RSI (14) is 45.46, which suggests ITOS is a Neutral.
      What is ITOS’s MACD?
      ITOS’s MACD is -0.09, which suggests ITOS is a Sell.
        What is ITOS’s 5-day moving average?
        ITOS’s 5-day moving average is 7.45, which suggests ITOS is a Sell.
          What is ITOS’s 20-day moving average?
          ITOS 20-day moving average is 7.48, which suggests ITOS is a Sell.
            What is ITOS’s 50-day moving average?
            ITOS’s 50-day moving average is 7.64, which suggests ITOS is a Sell.
              What is ITOS’s 200-day moving average?
              ITOS’s 200-day moving average is 11.99, which suggests ITOS is a Sell.
                What is ITOS’s Williams % R (14)?
                ITOS’s Williams % R (14) is -59.77, which suggests ITOS is a Buy.
                  What is ITOS’s CCI (14)?
                  ITOS’s CCI (14) is -8.68, which suggests ITOS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis